RecruitingNCT06810323

The ROAM Research Study Therapy (LTOT) Version

The Respiratory Oxygen Adherence Monitor System for COPD With Long Term Oxygen Therapy

Sponsor

University of Virginia

Enrollment

100 participants

Start Date

Jan 14, 2025

Study Type

OBSERVATIONAL

Conditions

Pulmonary Disease, Chronic Obstructive

Summary

The purpose of this research is to test a device being developed that can see how patients use oxygen therapy over a long period of time. This study will focus on developing a new display part called ROAM module which will be attached to your oxygen source. The display will provide easily-accessible information that can show how you interact with your supplies and the oxygen machine automatically without connecting the oxygen source to the internet or other devices.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study (called ROAM) is exploring long-term oxygen therapy (LTOT) — the use of supplemental oxygen at home — for patients with chronic lung conditions. It is assessing how well this therapy works, when it should be used, and its impact on quality of life. **You may be eligible if...** - You have a chronic lung condition such as COPD (chronic obstructive pulmonary disease) or a similar respiratory illness - Your oxygen levels are low enough to qualify for supplemental oxygen therapy - You are able to participate in research activities and provide consent **You may NOT be eligible if...** - Your condition is too unstable or severe for outpatient research participation - You are unable to use or manage home oxygen equipment - You do not meet the clinical oxygen threshold criteria Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.